Alcresta
is a Massachusetts-based pharmaceutical company that researches, develops, and markets novel enzyme-based products for the treatment of gastrointestinal disorders... Read moreAlcresta
is a Massachusetts-based pharmaceutical company that researches, develops, and markets novel enzyme-based products for the treatment of gastrointestinal disorders... Read more
News
Mar 03, 2025
Citybizlist
Alcresta : Alcresta Therapeutics Expands Leadership Team
Jan 17, 2025
Pharmabiz
Alcresta : US FDA clears expanded use of Alcresta Therapeutics' RELiZORB cartridge for paediatric patients 1 year of age and older
May 14, 2024
Pharmabiz
Alcresta : Alcresta Therapeutics announces commercial availability of nextgeneration RELiZORB cartridge
Mar 12, 2024
Citybizlist
Alcresta : Linden Capital Partners Acquires Alcresta Therapeutics
Dec 22, 2023
NS Medical Devices
Alcresta : Alcresta Therapeutics gets FDA nod for RELiZORB digestive enzyme cartridge
Sep 01, 2023
Pharmabiz
Alcresta : US FDA clears expanded use of Alcresta Therapeutics' RELiZORB cartridge for paediatric patients ages 2 to 5 years
Jul 25, 2023
PR Newswire
Press Release: Alcresta : Alcresta Therapeutics Announces Publication of Cystic Fibrosis Foundation Position Paper Confirming Inline Enzyme Cartridges are Safe and Effective
Mar 16, 2023
StreetInsider
Press Release: Alcresta : Alcresta Therapeutics Announces Preclinical Data Showing ALC-078 Cartridge Use in SBS Model Associated with Reduced Dependence on Parenteral Nutrition
Jan 16, 2023
REBusinessOnline
Alcresta : Alcresta Therapeutics Signs 14,441 SF Life Sciences Lease in Waltham, Massachusetts
Dec 05, 2022
Citybizlist
Alcresta : Alcresta Therapeutics Announces Move to New Corporate Headquarters in Waltham, MA
Alcresta Competitors
1
2
3
4
5
6
7
8
9
10